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Abstract
Background: Leptospirosis is considered a re-emerging infectious disease caused by pathogenic spirochaetes of
the genus Leptospira. Pathogenic leptospires have the ability to survive and disseminate to multiple organs after
penetrating the host. Leptospires were shown to express surface proteins that interact with the extracellular matrix
(ECM) and to plasminogen (PLG). This study examined the interaction of two putative leptospiral proteins with
laminin, collagen Type I, collagen Type IV, cellular fibronectin, plasma fibronectin, PLG, factor H and C4bp.
Results: We show that two leptospiral proteins encoded by LIC11834 and LIC12253 genes interact with laminin in a
dose - dependent and saturable mode, with dissociation equilibrium constants (KD) of 367.5 and 415.4 nM, respectively.
These proteins were named Lsa33 and Lsa25 (Leptospiral surface adhesin) for LIC11834 and LIC12253, respectively.
Metaperiodate - treated laminin reduced Lsa25 - laminin interaction, suggesting that sugar moieties of this ligand
participate in this interaction. The Lsa33 is also PLG - binding receptor, with a KD of 23.53 nM, capable of generating
plasmin in the presence of an activator. Although in a weak manner, both proteins interact with C4bp, a regulator of
complement classical route. In silico analysis together with proteinase K and immunoflorescence data suggest that
these proteins might be surface exposed. Moreover, the recombinant proteins partially inhibited leptospiral adherence
to immobilized laminin and PLG.
Conclusions: We believe that these multifunctional proteins have the potential to participate in the interaction of
leptospires to hosts by mediating adhesion and by helping the bacteria to escape the immune system and to overcome
tissue barriers. To our knowledge, Lsa33 is the first leptospiral protein described to date with the capability of binding
laminin, PLG and C4bp in vitro.
Background
Leptospirosis is a zoonosis caused by pathogenic species
of the genus Leptospira. Greater incidence of human
infection occurs in tropical and subtropical countries [1,2].
The transmission of leptospirosis has been correlated with
exposure of individuals in close proximity to wild or farm
animals [1,3]. Recently, the disease became prevalent in
cities with sanitation problems and large urban rodent
reservoirs that contaminate the environment through
their urine [4].
Pathogenic Leptospira spp. have ability to adhere and
rapidly disseminate within the host during the early stage
of infection. Surface - associated proteins are potential
targets to mediate host - pathogen interactions, and
therefore are likely to elicit several activities, including
adhesion. The adhesion of leptospires to ECM compo-
nents of the host was considered to be essential in the
initial stage of the infection [5]. Indeed, we have reported
that pathogenic leptospires are capable of binding several
ECM molecules [6]. To date, several leptospiral ECM
binding adhesins have been described [6–18]. After the
adhesion, pathogens have to overcome tissue barriers in
order to reach blood circulation and organs. We have
reported that leptospires have the ability of binding PLG
at their surface and that plasmin (PLA) can be generated
in the presence of activator [19]. In addition, Verma and
colleagues [20] and our group have described several lep-
tospiral proteins as PLG - binding receptors [17,18,21].
More recently, we have reported that PLA generation on
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Leptospira decreased opsonization and that it might be
an important aspect of the immune escape strategy and
survival [22].
L. interrogans serovar Copenhageni genome annotation
identified many unknown coding sequences predicted
to be surface exposed proteins. Characterization of
these proteins, with no previously assigned function,
should increase our understanding of this intriguing
pathogen’s biology. In this work, we present our stud-
ies with two leptospiral coding sequences, LIC11834
and LIC12253, named Lsa33 and Lsa25, respectively.
The genes were cloned and the proteins expressed
using E. coli. The recombinant proteins were purified
and their ability to bind various ECM and serum
components was evaluated. We report that these
proteins are novel surface adhesins capable of binding
to laminin. In addition, Lsa33 can also interact to
PLG and both proteins bind the complement regula-
tor of the classical pathway C4bp. We believe that
these proteins are likely to be involved in Leptospira -
host interactions.
Results
Bioinformatic analysis
The selected coding sequences, LIC11834 and LIC12253,
are genome annotated as hypothetical proteins, and one
of them, LIC11834, is a putative lipoprotein, having
lipoprotein signal peptide (signal peptidase II) and a
cleavage site between amino acids 17–18. According to
SMART web server, LIC11834 has a signal peptide from
1 to 21 amino acids and a FecR domain from amino acid
60 to 162. PFAM predicts that this domain is involved
in regulation of iron dicitrate transport and that FecR
is probably a sensor that recognizes iron dicitrate in
the periplasm. LIC12253 presents a signal peptide
from amino acid 1 to 21 and a DUF1566 (Domain of
Unknown Function) from amino acid 58 to 164 [23,24].
The LIC11834 coding sequence can be classified as
alpha - beta protein, being the percentage of 36.57 for
alpha-helix and 29.13 for beta strands secondary struc-
ture. In the case of coding sequence LIC12253, the pro-
tein can be classified as mixed, having a predicted
secondary structure composition percent of 11.01, 19.38
and 69.60 for alpha - helix, beta strands and others, re-
spectively. Cellular localization predicts as extra - cellular
(non-cytoplasmic branch) for both proteins. The solvent
accessibility composition (core/surface ratio) for the CDs
LIC11834 and LIC12253 is expected to be 59.87 and
66.52% of amino acid residues exposed with more than
16% of their surface, respectively. All the predictions
above were performed with PrecitedProtein web server
[25,26]. The presence and identity of both coding
sequences among Leptospira sequenced genomes are
depicted in Table 1.
Distribution and expression of LIC11834 and LIC12253
genes among Leptospira strains
The presence of LIC11834 and LIC12253 genes in patho-
genic strains and in one saprophytic strain was examined
by PCR with a pair of primers designed according to
L. interrogans serovar Copenhageni genome sequences.
The gene LIC11834 was amplified by PCR in all strains
belonging to the pathogenic species excluding in
L. santarosai serovar Shermani (Figure 1A). No DNA
amplification was detected in the non - pathogenic
L. biflexa serovar Patoc. In the case of LIC12253 gene,
DNA band was amplified in all pathogenic strains and a
less intense band was detected in the saprophytic strain
(Figure 1A). The expression of LIC11834 and LIC12253
genes was evaluated by PCR amplification of reversely
transcribed total RNA. LIC11834 gene product was
detected only in L. interrogans specie serovars Canicola,
Pomona, Copenhageni, Icterohaemorrhagiae and Hardjo.
No expression was observed in non-pathogenic strain.
LIC12253 gene expression could be identified in all
pathogenic strain tested (Figure 1B). Integrity of total
RNA used in RT - PCR experiments was assured by the
Table 1 Gene locus, given names, features, gene conservation, sequence of the primers employed for DNA
amplification, and molecular mass of expressed recombinant proteins
Gene
locus1
Given
name2
Description/
Function
Conservation
(identity)3
Sequence of primers
for PCR amplification
Molecular
mass
LIC11834 Lsa33 Putative
lipoprotein
Lai (99%)
LBH (87%)
LBP (31%)
F:5′CTCGAGGATCTACAAGGTGGGGTTTTTAC3′
XhoI
R:5′CCATGGTTACTGAGGTTTTACTTGGTCC3′
NcoI
33.1 kDa
LIC12253 Lsa25 Conserved
hypothetical
protein
Lai (100%)
LBH (77%)
LBP (39%)
F:5′ CTCGAGGAGGAGAAACCGGACGATAC 3′
XhoI
R:5′
CCATGGTTAGGGAAGACTTCTAACACATC3′
NcoI
24.07 kDa
1http://aeg.lbi.ic.unicamp.br/world/lic/; LIC: Leptospira interrogans Copenhageni
2Lsa: Leptospiral surface adhesin of 33 and 24 kDa; we have named the latter as Lsa25 because Lsa24 has been already described (Barbosa et al., 2006)
3 http://blast.ncbi.nlm.nih.gov/Blast.cgi/
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presence of a 1,042 - bp 16 S ribosomal cDNA fragment
in all samples (Figure 1B).
Cloning and characterization of recombinant proteins
The amplified DNA sequences of LIC11834 and LIC12253
were cloned into an E. coli pAE vector [27] and the corre-
sponding proteins were expressed as full-length with 6X
His sequence tag at their N - terminal. Expression of
recombinant proteins was elicited from cultures of E. coli
BL21 SI after addition of NaCl (300 mM). Recombinant
protein Lsa33 is expressed in its soluble form, while Lsa25
is expressed in its insoluble form, as inclusion bodies (data
not shown). Protein Lsa25 was recovered from inclusion
bodies after solubilization with 8 M urea. The purifica-
tion was performed by metal chelating chromatography
under normal (Lsa33) or denaturing condition, followed
by refolding by gradually removal of urea (Lsa25). The
proteins were recovered with 1.0 M imidazol. Evaluation
of protein purification has shown that most of the
contaminants were washed away and proteins were repre-
sented as single major bands. The recombinant protein
bands were further confirmed by western blotting probed
with monoclonal anti - His tag antibodies and with poly-
clonal antiserum raised against each protein (data shown).
The calculated 33.1 kDa and 24.07 kDa molecular masses
of the recombinant proteins comprise the vector fusion
plus the encoded amino acids. Structural integrity of the
purified proteins was assessed by circular dichroism (CD)
spectroscopy. The minima at 208 and 222 nm, and the
maximum at 192 nm in the CD spectrum showed the
high α - helical secondary structure content of both
recombinant proteins (data not shown).
Recognition of the LIC11834 and LIC12253 coding
sequences by immunofluorescence confocal microscopy
The assessment of the selected CDSs on the bacterial
cell membrane was performed using living organisms
and the liquid - phase immunofluorescence method.
Figure 1 Analysis of the LIC11834 and LIC12253 genes and their transcripts among different leptospiral strains. (A) Analysis by PCR of
the LIC11834 (2) and LIC12253 (3) genes in pathogenic serovars (L. interrogans, L.borgpetersenii, L. kirshnery, L. noguchi and L. santarosai) and in the
non - pathogenic L. biflexa strain. 16 S rRNA gene expression was used as an internal control (1). The negative control contained no DNA,
indicated by (−). (B) Analysis of the LIC11834 (2) and LIC12253 (3) transcripts by RT - PCR using 2 μg total RNA extracted from different serovars
belonging to the pathogenic species and the saprophytic L. biflexa serovar Patoc strain Patoc. 16 S rRNA gene expression was used as an internal
control (1). Reverse transcriptase present, +; reverse transcriptase omitted, -. The negative control contained no cDNA, indicated by (−).
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Leptospires were visualized by propidium iodide staining
(Figure 2, column A) followed by protein detection with
polyclonal mouse antiserum raised against each protein
in the presence of anti - mouse IgG antibodies conju-
gated to FITC. Green fluorescence could be observed in
Figure 2 column B, for LIC11834, LIC12253 and LipL32,
an outer membrane protein used as a positive control
[28], but not with GroEL, a protoplasmic - cylinder
marker, used as a negative control [29]. The localization
of the protein - green light lying on the leptospires was
achieved by merging both fields and the results obtained
are shown in Figure 2, column C.
Cellular localization of the LIC11834 and LIC12253 coding
sequences by protease assay
We have performed proteinase K accessibility assay by
using the previously described assay (37, 41) with
some modifications. Live leptospires were treated with
25 μg/ml of proteinase K and aliquots of the bacterial
suspensions were taken at time 0, 1, 3 and 5 h; the
suspensions were sedimented and the ressuspended
bacteria were used to coat microplates, followed by incu-
bation with polyclonal antibodies against each protein,
including the controls, LipL32 and DnaK, for outer [28]
and cytoplasmic [30] protein. The reactions proceeded as
described in Methods. The leptospiral coding sequences
LIC11834 and LIC12253 were both susceptible to prote-
ase treatment after 1 h incubation, similar to the positive
control LipL32 (Figure 3). Almost no reduction was
observed with DnaK cytoplasmic protein (Figure 3).
Recombinant protein Lsa25 is recognized by antibodies of
confirmed cases of leptospirosis
To examine whether LIC11834 and LIC12253 leptospiral
coding sequences are able to elicit an immune response
from an infected host, we evaluated the reactivity of the
recombinant proteins Lsa25 and Lsa33 with antibodies
present in serum samples of early (MAT -) and convales-
cent (MAT +) phases of leptospirosis patients. ELISA
was performed using 24 and 33 serum samples of
negative MAT and of positive MAT, respectively. The
recombinant protein Lsa33 was almost non-reactive with
samples from both phases of the disease (Figure 4A),
while Lsa25 showed 46 and 48% reactivity for negative
and positive MAT, respectively (Figure 4B). When the two
proteins were assayed together, a small increment was
Figure 2 Recognition of coding sequences LIC11834 and LIC12253
proteins in L. interrogans by their respective antibodies. Liquid -
phase Immunofluorescence Assay (L - IFA) was performed with live L.
interrogans under confocal microscopy using antiserum for LIC11834,
LIC12253, LipL32 (surface - exposed lipoprotein) and GroEL
(protoplasmic cylinder marker). Leptospires were identified by
propidium iodide staining of the DNA (A). FITC - conjugated secondary
antibodies were used to detect the surface - bound antibodies (B).
Co - localization is shown in the merged images (C).
Figure 3 Protease accessibility assay of LIC11834 and LIC12253
encoded proteins of L. interrogans. Viable leptospires were
incubated with 25 μg/ml of proteinase K at the indicated times. The
suspensions were sedimented, washed, ressuspended in PBS and
coated in a microplate. Antibodies against recombinant proteins
Lsa33, Lsa25, LipL32 and DnaK were added. After incubation, anti-IgG
peroxidase conjugated was added and the reaction was developed
with OPD peroxidase substrate. Blanks were run in parallels but
antibodies against the proteins were omitted. Readings were taken
at 492 nm. Bars represent the mean of absorbance ± the standard
deviation of three replicates for each protein and are representative
of three independent experiments. For statistical analyses, the signal
was compared between 0 hour and hours of treatment with PK by
two-tailed t test (*P< 0.05).
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observed for positive MAT samples (58%) (Figure 4C).
Our data suggest that Lsa25 might be an interesting
protein for early diagnose of leptospirosis.
Recombinant proteins adhesion to ECM components
The ability of Lsa33 and Lsa25 proteins to mediate host
colonization by adhering to extracellular matrix proteins
was examined by ELISA. Laminin, collagen Type I,
collagen Type IV, cellular fibronectin, plasma fibronectin,
and the control proteins fetuin and gelatin were immo-
bilized on microdilution wells and recombinant protein
attachment was assessed by ELISA using antibodies
against the proteins. As shown in Figure 5A, both
recombinant proteins exhibited adhesiveness to laminin,
while no statistically significant binding was observed
with these proteins when wells were coated with collagen
Type I and IV, cellular and plasma fibronectin, gelatin or
with the highly glycosylated control protein fetuin. The
interaction of recombinant proteins with laminin was
also observed when anti - polyhistidine monoclonal anti-
bodies were employed to probe the ligands (Figure 5B).
The binding between Lsa33 and Lsa25 with laminin was
also evaluated on a quantitative basis as depicted in
Figure 5C. A dose - dependent and saturable binding
Figure 4 Reactivity of the recombinant antigens Lsa33 and Lsa25 with serum samples of individuals diagnosed with leptospirosis.
Responders were determined by ELISA with the recombinant proteins and serum samples from patients of both phases of the disease. The reactivity
was evaluated as IgG antibodies. Serum was considered MAT positive or MAT negative if agglutination was detected when the sera were tested for
their reactivity’s with isolates of the 22 serovars (see Methods). The cutoff values are depicted as horizontal bars and were defined as the mean plus 3
standard deviations obtained for sera from 12 healthy individuals. (A) shows the data for Lsa33, (B) for Lsa25, and (C) depicts the data when both
proteins were employed (Lsa33 plus Lsa25).
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was observed when increasing concentrations of the
recombinant proteins (0–6 μM) were allowed to adhere
to a fixed laminin concentration (1 μg) (Figure 5C).
Binding saturation level was achieved by protein concen-
tration of ~4 and 5 μM for Lsa33 and Lsa25, respectively.
Based on ELISA data, the calculated dissociation equilib-
rium constants (KD) for the recombinant protein Lsa33
and Lsa25 with laminin is 367.5 and 415.4 nM, respect-
ively. The role of laminin sugar moieties in the binding
with Lsa33 and Lsa25 was assessed with laminin previ-
ously oxidized by increasing concentrations of sodium
metaperiodate, ranging from 5 to 100 mM. The effect
of metaperiodate concentration on the interaction is dis-
played in Figure 5D. Laminin oxidation had some effect
on the interaction with Lsa25, being the reduction of
40% achieved at the highest metaperiodate concentration
employed (100 mM). However, the attachment of Lsa33
to metaperiodate - treated laminin had no interference
on the binding. These results indicate that the binding of
the proteins to laminin occur in a different manner and
that sugar residues contribute to some extent for the
interaction of Lsa25 with this ECM glycoprotein.
Interaction of recombinant proteins to serum components
Our group has recently reported that leptospires interact
with PLG and that several proteins could act as PLG -
receptors [17–19,21]. Protein binding to complement
regulators factor H and C4bp have also been shown
[31,32]. Therefore, we set out to evaluate whether the
recombinant proteins Lsa33 and Lsa25 were capable of
binding human PLG, factor H and C4bp in vitro. The
components, human PLG, factor H and C4bp and the
control proteins, gelatin and fetuin, were individually
immobilized onto 96 - wells plates followed by incuba-
tion with the recombinant leptospiral proteins. The
results obtained using polyclonal antibodies against each
Figure 5 Binding characteristics of Lsa33 and Lsa25 proteins to ECM components. (A) Wells were coated with 1 μg of laminin, collagen
type I, collagen type IV, cellular fibronectin, plasma fibronectin and the control proteins gelatin and fetuin. One μg of the recombinant proteins
Lsa33 and Lsa25 was added per well and the binding was measured by ELISA. In (A) the protein binding was detected by polyclonal antibodies
against each protein, while in (B) protein binding was evaluated with monoclonal anti - polyhistidine serum. Data represent the mean± the
standard deviation from three independent experiments. For statistical analyses, the attachment of recombinant proteins to the ECM components
was compared to its binding to gelatin by the two - tailed t test (*P< 0.05). (C) Dose - dependent binding experiments of recombinant proteins
with laminin was performed by polyclonal antibodies against each protein; each point was performed in triplicate and expressed as the mean
absorbance value at 492 nm ± standard error for each point. Gelatin was included as a negative control. The dissociation constants (KD) are
depicted and were calculated based on ELISA data for the recombinant proteins that reached equilibrium. (D) Immobilized laminin was treated
with sodium metaperiodate (5 to 100 mM) for 15 min at 4°C in the dark. Mean absorbance values at 492 nm (± the standard deviations of three
independent experiments) were compared to those obtained with untreated laminin (0 mM).
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protein to probe the reactions showed that Lsa33 and
Lsa25 interact with C4bp while only Lsa33 appears to
bind to PLG (Figure 6A). No reaction was observed with
factor H and the control proteins (Figure 6A). Similar
results were achieved when binding was performed
using monoclonal anti - his tag antibodies (Figure 6B).
Both data show that while Lsa33 protein depicted a sta-
tistically significant absorption value for the interaction
with PLG, the Lsa25 appears to have only a weak or no
adherence to this component. These data were further
confirmed when the reaction between the recombinant
proteins and PLG were assessed on a quantitative basis
as illustrated in Figure 6C. Dose - dependent and satur-
able binding was observed when increasing concentra-
tions (0 to 1.0 μM) of the recombinant protein Lsa33
were allowed to adhere to a fixed PLG amount (1 μg),
while very low absorption was detected with Lsa25
(Figure 6C). Based on the ELISA data, the calculated KD
for the recombinant proteinLsa33 with PLG is
23.53 ± 4.66 nM (Figure 6C). This KD value is in the
same order of magnitude with the ones obtained with
several recombinant proteins in our laboratory [21].
PLG bound to leptospires and to several recombinant
proteins, acting as PLG receptor, can acquire proteolytic
activity in the presence of an activator, as we have previ-
ously shown [17–19,21]. Therefore, we investigated
whether Lsa33 bound to PLG could also generate the
enzymatically active plasmin. As a negative control, we
have included the recombinant protein Lsa63, previously
shown to be non-reactive with PLG [21]. Microplates
were coated with the test protein, blocked, and then
incubated with PLG. Unbound PLG was washed away
and the urokinase - type PLG activator (uPA) was added
together with a plasmin - specific chromogenic sub-
strate. The reaction was carried out overnight and the
plasmin activity was evaluated by measuring the cleavage
of the substrate (absorbance at 405 nm). As shown in
Figure 6D, the PLG captured by the Lsa33 protein could
be converted into plasmin, as demonstrated indirectly by
specific proteolytic activity. The negative controls Lsa63
and BSA did not show any proteolytic activity, similar to
the controls lacking PLG, uPA or the chromogenic
substrate.
The interaction of recombinant proteins with C4bp
was studied in function of protein concentration. We
have employed anti –Lsa33 and anti-Lsa25 polyclonal
(Figure 6E) and anti-His tag monoclonal antibodies
(Figure 6F) to probe the binding. Dose - response curves
were obtained with both antibodies but the best response
was achieved with anti-His tag monoclonal (Figure 6F),
probably because of their homogeneous nature. However,
C4bp was not saturated with the protein concentration
range employed and therefore the KD could not be calcu-
lated. Lsa63, a His - tag recombinant protein that does
not bind C4bp was also included, as a negative control,
showed very low interaction and did not respond to
increase protein concentration.
Inhibition of L. interrogans attachment to laminin or to
PLG by Lsa33 and Lsa25
It has been reported that the several recombinant
proteins with adhesin activity revealed an inhibitory
effect on the binding of leptospires to ECM macromole-
cules [6]. We therefore performed experiments to assess
whether the recombinant proteins had an effect on the
binding of Leptospira to laminin or PLG by employing
ELISA to detect the interaction in function of protein
concentration (0–10 μg). The results demonstrate that
the addition of increasing concentrations of Lsa33
reduced the leptospiral binding to laminin and to PLG
molecules in a dose - dependent manner (Figure 7A).
Binding decrease in the number of leptospires interact-
ing to laminin and PLG was statistically significant with
1.25 μg of Lsa33 (*, P< 0.05). This interference was
also evaluated with the binding of leptospires to laminin
in the presence of increasing concentrations of Lsa25
(0–10 μg), resulting in a similar effect as obtained with
Lsa33 (*, P< 0.05) (Figure 7B). We have also assessed
the competition for the binding of Lsa33 to PLG by
increasing laminin concentration (0 to 1.0 μg). The
results revealed that both ligands compete for the
binding with Lsa33 as a decrease of 40% in the binding
was already detected with 0.25 μg of laminin (*, P< 0.05)
(Figure 7C). These experiments were performed in tripli-
cate and Figure 7 shows one representative data of two
independent experiments.
Discussion
Complement is a key component of the innate immune
system responsible for protection against pathogenic
microorganisms [33]. Factor H is a host fluid - phase
regulator of the alternative complement pathway. Patho-
genic leptospiral complement - resistant strains were
found to bind factor H from human serum and this
interaction seems to be associated to their serum resist-
ance [31,34]. C4b - binding protein is an inhibitor of
complement classical pathway system. This protein con-
trols the complement classical pathway by interfering
with the formation and regeneration of C3 convertase
and acting as a cofactor to the serine proteinase factor I
in the proteolytic inactivation of C4b [33,35]. It has been
shown that pathogenic leptospiral strains can obtain
C4bp from the host and that this acquisition preserves
its cofactor activity [36]. The surface bound C4bp elicits
factor I mediated cleavage of C4b, an interaction that
appears to contribute to complement resistance by
Leptospira, through the classical route [37]. Leptospiral
binding proteins to C4bp, factor H and factor H - like
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Figure 6 Recombinant proteins binding to serum components. (A) Human purified PLG, factor H and C4bp (10 μg/ml) were coated onto
ELISA plates and allowed to interact with the recombinant proteins Lsa33 and Lsa25 (10 μg/ml). Gelatin and fetuin were used as negative controls
for nonspecific binding. The binding was detected by antibodies raised against each recombinant protein (1:750). Bars represent the mean of
absorbance at 492 nm± the standard deviation of three replicates for each protein and are representative of three independent experiments. For
statistical analyses, the binding of Lsa33 and Lsa25 was compared to its binding to gelatin by two - tailed t test (*P< 0.05 and **P< 0.005). (B)
Similar as described in (A) but the binding of the recombinant proteins was detected by anti - polyhistidine monoclonal antibodies (1:200).
Included is a His - tag recombinant protein Lsa63 that does not bind C4bp. (C) Recombinant proteins dose - dependent binding experiments
with PLG. The binding was detected by polyclonal antibodies against each protein; each point was performed in triplicate and expressed as the
mean absorbance value at 492 nm± standard error for each point. Gelatin was included as a negative control. The dissociation constant (KD) is
depicted and was calculated based on ELISA data for the recombinant protein that reached equilibrium. (D) Plasmin generation by PLG bound to
recombinant proteins was assayed by modified ELISA as immobilized proteins received the following treatment: PLG + uPA + specific plasmin
substrate (PLG + uPA + S), or controls lacking one of the three components (PLG + uPA; PLG + S; uPA + S). Lsa63 and BSA were employed as
negative controls. Bars represent mean absorbance at 405 nm, as a measure of relative substrate degradation ± the standard deviation of four
replicates for each experimental group and are representative of three independent experiments. Statistically significant binding in comparison to
the negative control (BSA) are shown: *P< 0.05. (E) Recombinant proteins dose - dependent binding experiments with C4bp. The binding was
detected by polyclonal antibodies raised against each protein (1:750); each point was performed in triplicate and expressed as the mean
absorbance value at 492 nm ± standard error for each point. Gelatin was included as a negative control. (F) Similar to (E) but the protein binding
was detected by anti-polyhistidine monoclonal antibodies (1:200); included is a His - tag recombinant protein Lsa63 that does not bind C4bp;
each point was performed in triplicate and expressed as the mean absorbance value at 492 nm ± standard error for each point. Gelatin was
included as a negative control.
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have also been identified in Leptospira [9,31,32]. Inter-
action of C4bp and of factor H with other pathogens has
been described, including the spirochetes Borrelia spp.
[33,37–41].
The capacity of the leptospires to adhere to extra-
cellular matrix components has been reported and to
date, several leptospiral adhesins have been identified.
These include 36 - kDa fibronectin - binding protein
[42], LfhA/Lsa24 [6,31], LigA and LigB proteins [7,8],
Len-family proteins [9], Lsa21 [10], LipL32 [12,43],
Lsa27 [13], Lp95 [11], TlyC [14], LipL53 [44], Lsa63 [15],
OmpL37 [45], Lsa66 [17] and Lsa20 [18]. We have
reported that Leptospira species were also capable to
bind PLG and generating plasmin, in the presence of
host activator, on the outer surface in vitro [19]. In
addition, we have described that plasmin - coated
virulent L.interrogans bacteria were capable to degrade
purified extracellular matrix components fibronectin [19]
and laminin (Vieira et al., unpublished data), a step that
may contribute for dissemination of the bacteria through
the host tissues. More recently, we have shown that
plasmin generation on the bacterial surface decreases the
deposition of C3b and IgG and hence, opsonization and
phagocytosis, a process that could facilitate leptospires to
evade the immune system [22]. Several PLG-receptor
proteins in Leptospira have been identified [17,18,20,21].
By data mining the genome sequences of L. interrogans,
searching for surface exposed proteins that could mediate
host - pathogen interactions, we have identified two pro-
teins annotated as Leptospira conserved hypothetical, one
of them, predicted to be a novel lipoprotein, LIC11834,
and the other, LIC12253, has recently been shown to be
non-protective in leptospiral challenge assay [46]. Both
selected coding sequences were cloned and the recombin-
ant proteins expressed in E. coli. We report that these pro-
teins, Lsa33 and Lsa25, are laminin - binding adhesins and
in the case of Lsa33, capable to bind PLG generating
enzymatically active plasmin. Although weak, both pro-
teins showed the ability to bind human purified C4bp,
suggesting that these proteins have the potential to partici-
pate in leptospiral immune evasion by interfering with the
complement classical pathway.
Due to the high degree of antigenic variation among
leptospires, we examined the gene/protein conservation
Figure 7 Inhibition of L. interrogans attachment to immobilized laminin and PLG by recombinant proteins; The effect of laminin
concentration on the binding of PLG to Lsa33. (A) Laminin or PLG (1 μg/well) was adsorbed onto microtiter plates followed by incubation with
increasing concentrations of Lsa33 (0 to 10 μg) and in (B) laminin was adsorbed onto microtiter plates followed by incubation with increasing
concentrations of Lsa25 (0 to 10 μg). In (A) and (B) the incubations were allowed to proceed for 90 min at 37°C. Live leptospires (100 μl/well of 4 X 107L.
interrogans serovar Copenhageni strain M20 leptospires) were added and incubated for another 90 min at 37°C. The unbound leptospires were washed
away, and the quantification of bound leptospires was performed indirectly by anti - LipL32 antibodies produced in mice (1: 4,000 dilution) followed by
horseradish peroxidase - conjugated antimouse IgG antibodies. Each point represents the mean absorbance value at 492 nm ± standard deviation of
three replicates. Data are representative of two independent experiments (*P< 0.05). (C) The effect of laminin on the binding of PLG (10 μg/ml) to
immobilized rLIC11834 (10 μg/ml) was assessed with the addition of increasing concentrations of laminin (0 to 1.0 μg). The detection of rLIC11834-bound
PLG was performed by use of specific antibodies anti - PLG. Bars represent the mean absorbance values ± standard deviation of four replicates for each
condition and are representative of two independent experiments. Results of statistically significant interference on the binding in comparison with the
control (no addition of laminin) are shown: *P< 0.05.
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among important species of Leptospira. The LIC11834
and LIC12253 genes are conserved in five serovars of
L. interrogans and in other species tested but in the case
of L. santarosai serovar Shermani the gene LIC11834 is
absent. However, LIC11834 transcripts were detected
only in serovars of L. interrogans, while LIC12253
appears to be expressed in all strains evaluated. None of
the proteins seems to be expressed in the saprophytic
strain, L. biflexa serovar Patoc.
The recombinant proteins Lsa33 and Lsa25 were
expressed with molecular mass of 33 - and 24 - kDa,
respectively, having a 6XHis tag at N - terminal. The
purified proteins exhibited single major bands in SDS -
PAGE and were recognized by anti - His tag monoclonal
antibodies and by homolog sera from mice immunized
with each recombinant protein. Secondary structure of
the recombinant proteins after the purification process
was evaluated by CD spectroscopy and showed a pre-
dominance of alpha helices in both cases, similar to the
data predicted by bioinformatics, indicating the suitabil-
ity of recombinant proteins for further studies. The
LIC12253 coding sequence is probably higher immuno-
genic than LIC11834 because it was recognized by
approximately 45% of serum samples of both phases, ini-
tial and convalescent, of confirmed leptospirosis’s cases.
Interestingly, the LIC11834 protein although presented
almost no reactivity among these serum samples, showed
a slightly augment effect on serum reactivity when was
assayed together with LIC12253. Immunofluorescence
using live leptospires showed LIC11834 and LIC12253
coding sequences at the surface of bacteria, as a result
of antiserum recognition raised against each protein.
In silico analysis, proteinase K accessibility and immuno-
fluorescence data together suggest that these proteins
are likely to be surface exposed. In addition, the recom-
binant proteins partially inhibited leptospiral adherence
to immobilized laminin and PLG.
Merien and colleagues [42] identified a 36-kDa fibro-
nectin-binding protein expressed by a virulent variant of
Leptospira. Our group described the first leptospiral lam-
inin - binding protein, named Lsa24 [6]. These studies
were followed by the identification of several extracellu-
lar matrix binding proteins [7,9–18]. The recombinant
proteins Lsa33 and Lsa25 exhibited extracellular matrix -
binding properties, and are laminin - binding proteins.
The binding affinity dissociation constants estimated for
both proteins to laminin showed similar KD value of that
reported for OmpL 37 (410 ± 81 nM) and the same ECM
molecule [16]. Thus, it is possible that these proteins
have a role in the adhesion of leptospires to hosts.
The PLG activation system with generation of plasmin
was described for virus, parasites and bacteria, including
the spirochetes Borrelia spp. and with Treponema
denticola [47–50]. Plasmin is a serine protease with the
capacity to degrade a broad spectrum of substrates,
including fibrin clots, connective tissue and components
of extracellular matrices [51–53]. We have reported that
Leptospira spp. bind PLG at their surface generating
plasmin, when host activator is available, making the
bacteria capable to degrade fibronectin [19] and laminin
(Vieira, M.L., unpublished results). Verma et al. [20] have
demonstrated that the protein LenA of L. interrogans [9]
is a surface receptor for human PLG. Moreover, we have
reported several novel PLG - receptor proteins of
Leptospira [17,18,21]. We now describe Lsa33 as a novel
PLG - binding protein. Similar to the previously reported
proteins, bound PLG could be converted to plasmin by
the addition of urokinase - type PLG activator (uPA),
showing specific proteolytic activity. It is thus possible
that the Lsa33 besides playing a role in the attachment
to host and acting as PLG - receptor, may also help lep-
tospires to surmount tissue barriers.
The inhibitory effect exerted on the binding of leptos-
pires to laminin and PLG by the recombinant proteins
was statistically significant with both, in the case of
Lsa33, and with laminin for the Lsa25. The intensity of
the interference upon the binding is expected given
the presence of several ECM - or PLG-binding proteins
in Leptospira. These data are comparable to the
ones already reported in the literature [6,7,16–18,21].
Partial inhibitory effect was observed by laminin on the
binding of Lsa33 to PLG, suggesting a competition for
the same binding site.
Conclusions
We report in these studies a characterization of two
leptospiral proteins, genome annotated as proteins of
unknown function. The recombinant proteins Lsa33
and Lsa25 are laminin binding proteins that might be
involved in the attachment to host. Moreover, both pro-
teins showed the ability to bind C4bp, a feature suggest-
ing their possible involvement in the immune evasion of
leptospires. The recombinant Lsa33 is also PLG - bind-
ing protein that could help the bacteria during the
infection process. Thus, it appears that Lsa33 and to a
lesser degree, Lsa25, are multifaceted proteins that might
have multiple functions in the leptospiral pathogenesis.
To date, Lsa33 is the first described laminin -, PLG - and
C4bp - leptospiral binding protein.
Methods
Leptospira strains and sera
The pathogenic Leptospira strains used were: L. interrogans
serovar Canicola strain Hound Utrech IV, L. interrogans
serovar Copenhageni strain M 20, L. interrogans serovar
Hardjo strain Hardjoprajitno, L. interrogans serovar Ictero-
haemorrhagiae strain RGA, L. interrogans serovar Pomona
strain Pomona, L. borgpetersenii serovar Whitcombi strain
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Whitcomb and serovar Grippothyphosa strain Moskva V,
L. kirshneri serovar Cynoptery strain 3522 C, L. santarosai
serovar Shermani strain 1342 K, L. noguchi serovar
Panama strain CZ 214 and L. biflexa serovar Patoc strain
Patoc, were cultured at 28°C under aerobic conditions in
liquid EMJH medium (DifcoW) with 10% rabbit serum,
enriched with L - asparagine (wt/vol: 0.015%), sodium
pyruvate (wt/vol: 0.001%), calcium chloride (wt/vol:
0,001%), magnesium chloride (wt/vol: 0.001%), peptone
(wt/vol:0.03%) and meat extract (wt/vol: 0.02%) (Turner
LH. Leptospirosis. 3. Maintenance, isolation and demon-
stration of leptospires. Trans R Soc Trop Med Hyg 1970;
64: 623–646). Leptospira cultures are maintained in Facul-
dade de Medicina Veterinária e Zootecnia, USP, São Paulo,
SP, Brazil. Confirmed - leptospirosis serum samples were
from Instituto Adolfo Lutz collection, São Paulo, Brazil.
Microscopic agglutination test (MAT)
The microscopic agglutination test was performed
according to [1]. In brief, an array of 22 serovars of
Leptospira spp. as antigens were employed: Australis,
Autumnalis, Bataviae, Canicola, Castellonis, Celledoni,
Copenhageni, Cynopteri, Djasiman, Grippotyphosa,
Hardjo, Hebdomadis, Icterohaemorrhagiae, Javanica,
Panama, Patoc, Pomona, Pyrogenes, Sejroe, Shermani,
Tarassovi and Wolffi. All the strains were maintained in
EMJH liquid medium (Difco, USA) at 29°C. A laboratory
- confirmed case of leptospirosis was defined by the
demonstration of a four - fold microagglutination titer
rise between paired serum samples. The probable
predominant serovar was considered to be the one with
the highest dilution that could cause 50% of agglutin-
ation. MAT was considered negative when the titer was
below 100.
Characterization of the protein in silico
Predicted coding sequence (CDSs) LIC11834 and
LIC12253 were identified on L. interrogans serovar
Copenhageni and selection was based on cellular
localization; cellular localization prediction was per-
formed by PSORT, http://psort.nibb.ac.jp [54] and Pre-
dictProtein web server, https://www.predictprotein.org/
[25]. The SMART [23] http://smart.embl-heidelbergde/
and PFAM [55] http://www.sanger.ac.uk/Software/Pfam/
web servers were used to search for predicted func-
tional and structural domains. The presence of lipobox
putative sequence was evaluated by use of the LipoP
program [56] http://www.cbs.dtu.dk/services/LipoP/. The
predicted sequence of the lipobox was also assessed by use
of the SpLip program, as described by Setubal et al. [57].
Secondary structure, solvent accessibility and cellular
localization predictions were also performed by using Pre-
dictProtein web server, https://www.predictprotein.org/ [25].
DNA isolation and PCR analysis
Leptospira cultures were harvested by centrifugation at
11,500 g for 30 min and gently washed in sterile PBS
twice. Genomic DNA was isolated from the pellets by
guanidine - detergent lysing method using DNAzolW
Reagent (Invitrogen), according to the manufacturer’s
instructions. Primers were designed according to
L. interrogans serovar Copenhageni genome sequences
(GenBank accession AE016823) and are listed in Table 1.
PCR was performed in a reaction volume of 25 μl con-
taining 100 ng of genomic DNA, 1 × PCR buffer (20 mM
Tris - HCl, pH 8.4, 50 mM KCl), 2 mM MgCl2, 20 pmol
of each specific primer, 200 μM of each dNTP, and 2.5 U
Taq DNA Polymerase (Invitrogen). Cycling conditions
were: 94 ° C - 4 min, followed by 40 cycles at 94°C -
50 sec, 57°C (LIC11834) or 56°C (LIC12253) - 50 sec, 72°C
- 90 sec, and a final extension cycle of 7 min at 72°C. PCR
amplified products were loaded on a 1% agarose gel for
electrophoresis and visualization with ethidium bromide.
RNA extraction and RT-PCR analysis
For reverse transcription RT - PCR, total RNA was iso-
lated by the acid guanidinium thiocyanate phenol -
chloroform method using TRIzolW Reagent (Invitrogen)
according to the manufacturer’s recommendations. 1 μg
of RNA from each sample was treated with 1 U of
DNAse I Amplification Grade (Invitrogen) for 15 min at
room temperature. DNAse I was inactivated by the
addition of 1 μl of 25 mM EDTA solution followed by an
incubation at 65 ° C for 10 min. DNAse - treated RNAs
were reversely transcribed using the SuperScript™ III First
- Strand Synthesis System for RT-PCR (Invitrogen). One
tenth of RT products were amplified in a 25 μl reaction
mix using oligonucleotides LIC11834 - F/LIC11834 - R
or LIC12253 - F/LIC12253 - R, as described above.
Samples quantity and integrity were verified by amplifi-
cation of a 1,042 bp 16 S ribosomal cDNA fragment
using oligomers:
16S - F 5′
CAAGTCAAGCGGAGTAGCAATACTCAGC 3′ and
16S - R 5′GATGGCAACATAAGGTGAGGGTTGC 3′.
DNA recombinant techniques, protein expression
and purification
Predicted CDSs LIC11834 and LIC12253, without signal
peptides, were amplified by the PCR from L. interrogans
serovar Copenhageni strain Fiocruz L1 - 130 genomic
DNA using the primer pairs depicted in Table 1. The
PCR products obtained for each corresponding gene
were cloned into pGEM-T easy vector (Promega) and
subcloned into the pAE expression vector [27] at the
restriction sites shown in Table 1. The pAE vector allows
the expression of recombinant proteins with a minimal
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6X His - tag at the N - terminus. All cloned sequences
were confirmed by DNA sequencing with an ABI 3100
automatic sequencer (PE Applied Biosystems, Foster city,
CA). Protein expression of rLIC11834 and rLIC12253
was achieved in E. coli BL21 (SI) strain by the action of
T7 DNA polymerase under control of the osmotically
induced promoter proU [58] . E. coli BL21 (SI) contain-
ing recombinant plasmids were grown at 30°C in
Luria - Bertani broth without NaCl and with 100 μg/ml
ampicillin with continuous shaking until an optical dens-
ity at 600 nm of 0.6 to 0.8 was reached. Recombinant
protein synthesis was induced by the addition of
300 mM NaCl. After three hours, the cells were har-
vested by centrifugation and the bacterial pellets resus-
pended in lysis buffer (200 μg/ml of lysozyme, 1% Triton
X - 100, 2 mM phenylmethylsulfonyl fluoride [PMSF]).
The bacterial cell pellets were lysed on ice with the aid
of a sonicator (Ultrasonic Processor; GE Healthcare).
The insoluble fractions were washed with 20 ml of buffer
(20 mM Tris - HCl, pH 8.0, 500 mM NaCl, 1 M urea
and 1% Triton X-100) and resuspended in a buffer con-
taining 20 mM Tris - HCl, pH 8.0, 500 mM NaCl, 5 mM
Imidazole, 1 mM β - mercaptoethanol and 8 M urea.
The proteins were then purified through metal chelating
chromatography in a Sepharose fast flow column
(GE Healthcare) and fractions were analyzed in 12%
SDS-PAGE. The rLIC12253 protein was refolded by 500
times dilution with 20 mM Tris - HCL, pH 8.0, and
500 mM NaCl before chromatographic purification. The
purified recombinant proteins were extensively dialyzed
against phosphate - buffered saline (PBS), pH 7.4, 0.1%
(wt/vol) glycine solution (1:100), pooled and stored at −20°C.
Circular dichroism spectroscopy
Purified recombinant proteins were dialyzed against
sodium phosphate buffer (pH 7.4). Circular dichroism
(CD) spectroscopy measurements were performed at 20°
C using a Jasco J-810 spectropolarimeter (Japan Spec-
troscopic, Tokyo) equipped with a Peltier unit for
temperature control. Far-UV CD spectra were measured
using a 1 mm - path - length cell at 0.5 nm intervals.
The spectra were presented as an average of five scans
recorded from 185 to 260 nm. The molar ellipticity (Φ)
is expressed in deg.cm.dmol1.
Antiserum
Five female BALB/c mice (4–6 weeks old) were immu-
nized subcutaneously with 10 μg of the recombinant
proteins. The recombinant proteins were adsorbed in
10% (vol/vol) of Alhydrogel (2% Al(OH)3, Brenntag
Biosector, Denmark), used as adjuvant. Two subsequent
booster injections were given at two - week intervals
with the same preparation of 10 μg of the proteins.
Negative - control mice were injected with PBS. One
week after each immunization, the mice were bled from
the retro - orbital plexus and the pooled sera were
analyzed by enzyme -linked immunosorbent assay (ELISA)
for determination of antibody titers. All animal studies
were approved by the Ethics Committee of the Instituto
Butantan, São Paulo, SP, Brazil. The Committee in Animal
Research in Instituto Butantan adopts the guidelines of the
Brazilian College of Animal Experimentation.
Immunoblotting assay
The purified recombinant proteins were loaded into 12%
SDS - PAGE and transferred to nitrocellulose membranes
(Hybond ECL; GE Healthcare) in semi - dry equipment.
Membranes were blocked with 5% non-fat dried milk and
2.5% BSA in PBS containing 0.05% Tween 20 (PBS - T)
and then incubated with anti - rLIC11834 (1:500), anti -
rLIC12253 (1:500) mouse serum or anti - his antibody
(1:1,000) (GE Healthcare) for 2 h at room temperature.
After washing, the membranes were incubated with
horseradish peroxidase (HRP) - conjugated anti - mouse
IgG (1:5,000; Sigma) in PBS - T for 1 h. The protein’s
reactivity was revealed by ECL reagent kit chemilu-
minescence substrate (GE Healthcare) with subsequent
exposition to X - Ray film.
ELISA for detection of human antibodies
Human IgG antibodies against Lsa33 or Lsa25 were
detected by ELISA as previously described [59]. In brief,
serum samples of negative (24) and positive (33) MAT
from confirmed - leptospirosis patients were diluted
1:400 and evaluated for total IgG using goat HRP -
conjugated anti-human IgG antibodies (1:5,000, Sigma).
Cutoff values were set at three standard deviations
above the mean OD492nm of sera from 11 health indi-
viduals, unexposed to leptospirosis, from the city of
São Paulo, Brazil and one pool of normal serum
samples from USA (Sigma).
Proteinase K accessibility assay
Suspensions of 5 ml live leptospires/per treatment
(~108cells/ml) were harvested at 10,000 rpm for 15 min
at room temperature, washed once with PBS (with
50 mM NaCl), resuspended in 5 ml of PBS (with 50 mM
NaCl) plus with 25 μg/ml of proteinase K (PK) (Sigma
Aldrich). Four similar test tubes were then incubated for
0 to 5 h at 37°C and aliquots were taken at 0, 1, 3 and
5 h before the addition of 100 mM of phenylmethyl-
sulfonyl fluoride (PMSF) to stop PK activity. The sus-
pensions were subsequently pelleted by centrifugation
at 10,000 rpm for 5 min, washed twice with PBS (with
50 mM NaCl) and resuspended in 1 ml PBS (with
50 mM NaCl) for ELISA analysis using antibodies
against Lsa33, Lsa25, Lip32 and DnaK, as described
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below. LipL32 and DnaK are membrane and cytoplasmic
leptospiral proteins that were employed in our experiment
as positive and negative control, respectively.
ELISA for detection cellular localization of the proteins
Leptospires were coated onto microplates and allowed to
stand at room temperature for 16 h. The plates were
washed three times with PBS (with 50 mM NaCl) and
blocked with 5% non-fat dry milk and 1% BSA for 2 h at
37°C. After incubated for 2 h at 37°C with polyclonal
mouse anti - serum against Lsa33, Lsa25, LipL32 or
DnaK (dilution of an OD equal to 1). The leptospires
were washed three times with PBS (with 50 mM NaCl)
and incubated with 50 μL of a 1:5,000 dilution of HRP -
conjugated goat anti - mouse IgG (Sigma) in PBS
(with 50 mM NaCl) for 1 h at 37°C. The wells were
washed three times with PBS (with 50 mM NaCl), and
o - phenylenediamine (OPD) (1 mg/mL) in citrate phos-
phate buffer (pH 5.0) plus 1 μL/mL H2O2 was added
(100 μL per well). The reaction proceeded for 5 min and
was interrupted by the addition of 50 μL of 4 N H2SO4.
The absorbance at 492 nm was determined in a micro-
plate reader (TP - reader, Thermo) against the O.D. of
blanks, containing all the reaction mixture but antibodies
against the proteins. For statistical analyses, the binding
of polyclonal mouse anti - serum against Lsa33, Lsa25,
LipL32 or DnaK at 0 h incubation was compared with
other incubations by Student’s two - tailed t test.
Binding of recombinant proteins to ECM and to serum
components
Protein attachment to individual macromolecules of the
extracellular matrix was analyzed according to a previ-
ously published protocol [6] with some modifications.
Briefly, 96 - well plates (Costar High Binding, Corning)
were coated with 1 μg of laminin, collagen type I, colla-
gen type IV, cellular fibronectin, plasma fibronectin,
human PLG, factor H, C4bp, or gelatin (negative control)
and fetuin (highly glycosylated attachment - negative
control protein) in 100 μL of PBS for 3 h at 37°C. The
wells were washed three times with PBS - T and then
blocked with 200 μL of 10% (wt/vol) non-fat dry milk
(overnight at 4°C). One microgram of each recombinant
protein was added per well in 100 μL of PBS, and protein
was allowed to attach to the different substrates for 2 h
at 37°C. After washing six times with PBS - T, bound
Lsa33 or Lsa25 was detected by adding mouse anti -
recombinant proteins (1:750) in 100 μL of PBS or anti -
His tag monoclonal (1:200) in 100 μL of PBS. Incubation
proceeded for 1 h at 37°C. After three washings with
PBS - T, 100 μL of a 1:5,000 dilution of HRP - conju-
gated goat anti - mouse IgG (Sigma) in PBS was added
per well for 1 h at 37°C. The wells were washed three
times, and o - phenylenediamine (OPD) (1 mg/mL) in
citrate phosphate buffer (pH 5.0) plus 1 μL/mL H2O2
was added (100 μL per well). The reaction proceeded for
10 min and was interrupted by the addition of 50 μL of
4 N H2SO4. The absorbance at 492 nm was determined
in a microplate reader (TP - reader, Thermo). For statis-
tical analyses, the binding of recombinant proteins to
ECM macromolecules and to serum components were
compared to its binding to gelatin and by Student’s two -
tailed t test.
Metaperiodate treatment of laminin
Microtitre wells were coated with 1 μg of laminin in
50 mM sodium acetate buffer, pH 5.0, and incubated for
16 h at 4°C. Wells were washed three times with the
same buffer, and laminin was treated with different so-
dium metaperiodate concentrations (0–100 mM) in the
same buffer for 15 min at 4°C in the dark. After three
washes with 50 mM sodium acetate buffer, wells were
blocked with 200 μl of 1% BSA for 1 h at 37°C. Binding
of recombinant proteins (1 μg in PBS per well) to period-
ate - treated laminin was evaluated as described above.
Dose–response curves
First, 96 - well plates were coated overnight in PBS at 4°
C with 100 μl of 10 μg/ml PLG, laminin or C4bp. Plates
were then blocked and increasing concentrations of the
purified recombinant proteins (0–6 μM) were added
(100 μl/well in PBS). The assessment of bound proteins
was performed by incubation for 1 h at 37°C with the
antiserum raised against each protein at the dilution of
1:750, followed by HRP - conjugated goat anti-mouse
IgG (Sigma) (1:5,000 in PBS). The reactions were
detected with OPD as describe above. The ELISA data
were used to calculate the dissociation constant (KD)
according to the method described by Pathirana et al.
[60] and Lin et al. [61], based on the equation: A ¼
Amax protein½ = KD þ protein½ ð Þ , where A is the absorb-
ance at a given protein concentration, Amax is the max-
imum absorbance for the ELISA plate reader
(equilibrium), [protein] is the protein concentration and
KD is the dissociation equilibrium constant for a given
absorbance at a given protein concentration (ELISA data
point).
Plasmin enzymatic activity assay
96 - well ELISA plates were coated overnight with
10 μg/ml recombinant proteins in PBS at 4°C. Lsa63,
which does not bind PLG [21] and BSA were employed
as negative control. Plates were washed once with PBS -
T and blocked for 2 h at 37°C with PBS with 10% (wt/
vol) non - fat dry milk. The blocking solution was dis-
carded and 100 μl/well of 10 μg/ml human PLG was
added, followed by incubation for 2 h at 37°C. Wells
were washed three times with PBS - T, and then 4 ng/
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well of human uPA (Sigma - Aldrich) were added. Subse-
quently, 100 μl/well of plasmin - specific substrate D -
valyl - leucyl – lysine - p - nitroanilide dihydrochloride
(Sigma - Aldrich) were added at a final concentration of
0.4 mM in PBS. Plates were incubated overnight at 37°C
and substrate degradation was measured by readings at
405 nm.
Inhibition of live leptospires binding to laminin or to PLG
by recombinant proteins
ELISA plates were coated with laminin or PLG (1 μg/
well). The plates were washed and blocked with 10% non
- fat dry milk in PBS - T for 2 h at 37°C. The blocking
solution was discarded, and the wells were incubated for
90 min at 37°C with increasing concentrations of pro-
teins (0 to 10 μg). After three washings, 50 μL/well of
4 × 107 live low - passage virulent L. interrogans serovar
Copenhageni strain M20 were added for 90 min at 37°C.
The unbound leptospires were washed and the quantifi-
cation of bound leptospires was performed indirectly by
anti - LipL32 antibodies produced in mice (1:4,000),
given the fact that LipL32 is a major outer membrane
leptospiral protein [28]; the procedure was followed by
horseradish peroxidase - conjugated anti - mouse IgG
antibodies, essentially as described in Barbosa et al. [6].
The detection was performed by OPD as previously
described.
Liquid-phase immunofluorescence assay (L - IFA)
The localization of LIC11834 and LIC12253 encoded
proteins by L - IFA was performed as described by Oli-
veira et al. [15]. In brief, suspensions of 2.5 ml live lep-
tospires (~109cells/ml) were harvested at 10,000 rpm for
15 min, washed twice with PBS (with 50 mM NaCl),
resuspended in 200 μl of PBS with 6 μg/ml propidium
iodide to stain the nuclei, and incubated for 45 min at
37°C. After incubation, the leptospires were washed gen-
tly with PBS and incubated for 30 min at 4°C with poly-
clonal mouse anti - serum against Lsa33, Lsa25, LipL32
or GroEL at a 1:50 dilution. The leptospires were washed
and incubated with goat anti - mouse IgG antibodies
conjugated to fluorescein isothiocyante (FITC, Sigma) at
a dilution 1:50 for 30 min at 4°C. After incubation with
secondary antibody, the leptospires were washed and
resuspended in PBS - antifading solution (ProLong Gold,
Molecular Probes). The immunofluorescence - labeled
leptospires were examined by employ of a confocal LSM
510 META immunofluorescence microscope (Zeiss,
Germany).
Nucleotide sequence accession numbers
GenBank accession numbers for protein sequences
LIC11834 and LIC12235 are AAS70420 and AAS70825,
respectively. The protein can also be accessed by the
genome nomenclature for the gene locus, LIC number
(Leptospira interrogans serovar Copenhageni).
ECM and biological components
The control proteins fetuin and gelatin, were purchased
from Sigma Chemical Co. (St. Louis, Mo.) and DifcoW,
respectively. Laminin - 1 and collagen Type IV were
derived from the basement membrane of Engelbreth -
Holm-Swarm mouse sarcoma, cellular fibronectin was
derived from human foreskin fibroblasts, plasma fibro-
nectin was isolated from human plasma and collagen
Type I was isolated from rat tail. PLG, purified from
human plasma, was purchased from Merck. Human Fac-
tor H was from Calbiochem. C4bp was from Comple-
ment Technology, INC.
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